RAR -PLZF overcomes PLZF-mediated repression of CRABPI, contributing to retinoid resistance in t(11;17) acute promyelocytic leukemia-Reference-Cited by-同舟云学术

RAR -PLZF overcomes PLZF-mediated repression of CRABPI, contributing to retinoid resistance in t(11;17) acute promyelocytic leukemia

Published:2007-11-13 Issue:47 Volume:104 Page:18694-18699
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proceedings of the National Academy of Sciences

Author:

Guidez F.,Parks S.,Wong H.,Jovanovic J. V.,Mays A.,Gilkes A. F.,Mills K. I.,Guillemin M.-C.,Hobbs R. M.,Pandolfi P. P.,de The H.,Solomon E.,Grimwade D.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference62 articles.

1. Role of Nuclear Receptor Corepressors in Leukemogenesis

2. Disruption of differentiation in human cancer: AML shows the way

3. Genetics of Myeloid Malignancies: Pathogenetic and Clinical Implications

4. Recruitment of the nuclear receptor corepressor N-CoR by the TEL moiety of the childhood leukemia–associated TEL-AML1 oncoprotein

5. Deconstructing a Disease: RAR, Its Fusion Partners, and Their Roles in the Pathogenesis of Acute Promyelocytic Leukemia

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retinoic acid signaling in development and differentiation commitment and its regulatory topology;Chemico-Biological Interactions;2024-01

2. Function of PML-RARA in Acute Promyelocytic Leukemia;Advances in Experimental Medicine and Biology;2024

3. An Acute Promyelocytic Leukemia Resistant to All-Trans Retinoic Acid: A Case Report of the <i>ZBTB16::RARa</i> Variant and Review of the Literature;Case Reports in Oncology;2023-11-23

4. Differentiation therapy using low‐dose venetoclax in a variant acute promyelocytic leukaemia carrying ZBTB16‐RARA ;British Journal of Haematology;2022-09-28

5. The MYCN inhibitor BGA002 restores the retinoic acid response leading to differentiation or apoptosis by the mTOR block in MYCN-amplified neuroblastoma;Journal of Experimental & Clinical Cancer Research;2022-04-30